Literature DB >> 2843664

Altered replicase specificity is responsible for resistance to defective interfering particle interference of an Sdi- mutant of vesicular stomatitis virus.

C Giachetti1, J J Holland.   

Abstract

The in vitro resistance of an Sdi- mutant of vesicular stomatitis virus to interference by wild-type defective interfering (DI) particles was expressed quantitatively in a cell-free replication system derived from mutant-infected cells. Added wild-type DI particle templates were replicated very poorly by extracts of Sdi- mutant-infected cells. However, the addition of purified viral polymerase (a complex of L and NS proteins) from wild-type vesicular stomatitis virus allowed efficient replication of wild-type DI particle genomes in these cell extracts. Added wild-type NS protein alone did not complement DI particle genome replication in these cell extracts, but it did complement a defect in the in vitro transcriptional activity of Sdi- mutant virus. These results clearly implicate the vesicular stomatitis virus polymerase complex in the inability of Sdi- mutants to replicate DI particles and in the quantitative escape from DI particle interference in evolving virus populations.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2843664      PMCID: PMC253502          DOI: 10.1128/JVI.62.10.3614-3621.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  The role of polypeptides L and NS in the transcription process of vesicular stomatitis virus New Jersey using the temperature-sensitive mutant tsE1.

Authors:  J Ongrádi; C Cunningham; J F Szilágyi
Journal:  J Gen Virol       Date:  1985-05       Impact factor: 3.891

2.  Cyclic production of vesicular stomatitis virus caused by defective interfering particles.

Authors:  E L Palma; A Huang
Journal:  J Infect Dis       Date:  1974-04       Impact factor: 5.226

3.  Ribonucleic acid synthesis of vesicular stomatitis virus. IV. Transcription by standard virus in the presence of defective interfering particles.

Authors:  A S Huang; E K Manders
Journal:  J Virol       Date:  1972-06       Impact factor: 5.103

Review 4.  Origin and replication of defective interfering particles.

Authors:  J Perrault
Journal:  Curr Top Microbiol Immunol       Date:  1981       Impact factor: 4.291

5.  Homotypic and heterotypic exclusion of vesicular stomatitis virus replication by high levels of recombinant polymerase protein L.

Authors:  E Meier; G G Harmison; M Schubert
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

6.  Vesicular stomatitis virus mutants resistant to defective-interfering particles accumulate stable 5'-terminal and fewer 3'-terminal mutations in a stepwise manner.

Authors:  P J O'Hara; F M Horodyski; S T Nichol; J J Holland
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

7.  Vesicular stomatitis virus defective interfering particles can contain extensive genomic sequence rearrangements and base substitutions.

Authors:  P J O'Hara; S T Nichol; F M Horodyski; J J Holland
Journal:  Cell       Date:  1984-04       Impact factor: 41.582

8.  Detection of vesicular stomatitis virus RNA and its defective-interfering particles in individual mouse brains.

Authors:  D R Cave; F S Hagen; E L Palma; A S Huang
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

9.  Persistent noncytocidal vesicular stomatitis virus infections mediated by defective T particles that suppress virion transcriptase.

Authors:  J J Holland; L P Villarreal
Journal:  Proc Natl Acad Sci U S A       Date:  1974-08       Impact factor: 11.205

10.  Initiation and replication of vesicular stomatitis virus genome RNA in a cell-free system.

Authors:  R W Peluso; S A Moyer
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

View more
  12 in total

1.  Nonlinear trade-offs allow the cooperation game to evolve from Prisoner's Dilemma to Snowdrift.

Authors:  Lin Chao; Santiago F Elena
Journal:  Proc Biol Sci       Date:  2017-05-17       Impact factor: 5.349

2.  Conserved motifs in a tombusvirus polymerase modulate genome replication, subgenomic transcription, and amplification of defective interfering RNAs.

Authors:  Chaminda D Gunawardene; Karolina Jaluba; K Andrew White
Journal:  J Virol       Date:  2015-01-07       Impact factor: 5.103

Review 3.  Defective interfering influenza virus RNAs: time to reevaluate their clinical potential as broad-spectrum antivirals?

Authors:  Nigel J Dimmock; Andrew J Easton
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

4.  Extreme heterogeneity in populations of vesicular stomatitis virus.

Authors:  D A Steinhauer; J C de la Torre; E Meier; J J Holland
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

5.  Design requirements for interfering particles to maintain coadaptive stability with HIV-1.

Authors:  Igor M Rouzine; Leor S Weinberger
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

6.  Phosphorylation of vesicular stomatitis virus phosphoprotein P is indispensable for virus growth.

Authors:  Subash C Das; Asit K Pattnaik
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

7.  Defective interfering influenza virus confers only short-lived protection against influenza virus disease: evidence for a role for adaptive immunity in DI virus-mediated protection in vivo.

Authors:  Paul D Scott; Bo Meng; Anthony C Marriott; Andrew J Easton; Nigel J Dimmock
Journal:  Vaccine       Date:  2011-07-14       Impact factor: 3.641

Review 8.  The Antiviral and Antitumor Effects of Defective Interfering Particles/Genomes and Their Mechanisms.

Authors:  Yicheng Yang; Taibiao Lyu; Runing Zhou; Xiaoen He; Kaiyan Ye; Qian Xie; Li Zhu; Tingting Chen; Chu Shen; Qinghua Wu; Bao Zhang; Wei Zhao
Journal:  Front Microbiol       Date:  2019-08-09       Impact factor: 5.640

Review 9.  Effects of defective interfering viruses on virus replication and pathogenesis in vitro and in vivo.

Authors:  L Roux; A E Simon; J J Holland
Journal:  Adv Virus Res       Date:  1991       Impact factor: 9.937

Review 10.  Exploiting Genetic Interference for Antiviral Therapy.

Authors:  Elizabeth J Tanner; Karla A Kirkegaard; Leor S Weinberger
Journal:  PLoS Genet       Date:  2016-05-05       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.